
Indoco Remedies receives final ANDA approval from USFDA for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg
Mumbai: Indoco Remedies Ltd. announced final approval of the Company’s Abbreviated New Drug Application (ANDA) for Rivaroxaban Tablets USP, 2.5 mg, 10 mg,














